Clinical Trials
48
Active:23
Completed:17
Trial Phases
3 Phases
Phase 1:16
Phase 2:14
Phase 3:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (36 trials with phase data)• Click on a phase to view related trials
Phase 1
16 (44.4%)Phase 2
14 (38.9%)Phase 3
6 (16.7%)Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Pharming Technologies B.V.
- Target Recruit Count
- 12
- Registration Number
- NCT06990529
- Locations
- 🇺🇸
National Institute of Health, Bethesda, Maryland, United States
Leniolisib for Immune Dysregulation in CVID
- First Posted Date
- 2025-03-26
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Pharming Technologies B.V.
- Target Recruit Count
- 20
- Registration Number
- NCT06897358
- Locations
- 🇺🇸
Lahey Hospital & Medical Center, Burlington, Massachusetts, United States
Leniolisib for Immune Dysregulation in PIDs
- First Posted Date
- 2024-08-12
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- Pharming Technologies B.V.
- Target Recruit Count
- 12
- Registration Number
- NCT06549114
- Locations
- 🇺🇸
National Institute of Health, Bethesda, Maryland, United States
An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Pharming Technologies B.V.
- Target Recruit Count
- 3
- Registration Number
- NCT06249997
- Locations
- 🇯🇵
Tokyo Medical And Dental University Hospital, Tokyo, Bunkyo-ku, Japan
🇯🇵Hiroshima University Hospital, Hiroshima, Hiroshima City, Japan
A trial to test the effect of leniolisib in children from 1 to 6 years of age with APDS
Phase 3
Active, not recruiting
- Conditions
- Activated Phosphoinositide 3-Kinase Delta Syndrome
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- Pharming Technologies B.V.
- Target Recruit Count
- 4
- Registration Number
- 2022-502180-38-00
- Locations
- 🇪🇸
University Hospital Virgen Del Rocio S.L., Sevilla, Spain
🇵🇹Unidade Local De Saude De Coimbra E.P.E., Coimbra, Portugal
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found